Skip to main content

Table 2 Comparison of other information between both groups

From: Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III–IVA esophageal squamous cell carcinoma post-surgery

 

Observation group

Control group

P-value

R0 resection rate

33/34 (97.06%)

34/36 (94.44%)

1.0

Intraoperative bleeding volume (ml)

100 (92.5,150)

100 (100,200)

0.370

Surgery time (min)

212 (192, 240.72)

205 (188.25,241)

0.540

Recurrent laryngeal nerve injury rate

1/34 (2.94%)

1/36 (2.78%)

1.0

Thoracic duct injury rate

0/34

0/36

1.0

Anastomotic fistula rate

3/34 (8.82%)

6/36 (16.67%)

0.479

Number of postoperative hospital days (d)

12 (9.25,16)

14 (10,20.75)

0.289

Postoperative lung infection rate

7/34 (20.59%)

7/36 (19.44%)

0.905